Manager, Commercial Insights & Analytics
Arrowhead Pharmaceuticals
Summary
The Manager, Commercial Insights & Analytics will play a pivotal role in the commercialization of Redemplo (plozasiran). This product has demonstrated compelling clinical data to date, with approval from the FDA and other regulatory bodies for its use in Familial Chylomicronemia Syndrome (FCS). With the recent release of phase 3 clinical trial data in Severe Hypertriglyceridemia (sHTG), Arrowhead is pursuing expanded regulatory approval for Plozasiran in this indication. Over time, the role will expand to cover additional indications and products in the Arrowhead portfolio.
Job description
The Position
The Manager, Commercial Insights & Analytics will play a pivotal role in the commercialization of Redemplo (plozasiran). This product has demonstrated compelling clinical data to date, with approval from the FDA and other regulatory bodies for its use in Familial Chylomicronemia Syndrome (FCS). With the recent release of phase 3 clinical trial data in Severe Hypertriglyceridemia (sHTG), Arrowhead is pursuing expanded regulatory approval for Plozasiran in this indication. Over time, the role will expand to cover additional indications and products in the Arrowhead portfolio.
In this position, you will play a key role in the lifecycle management of Plozasiran, launch preparedness and post launch performance diagnosis. You will have the opportunity to conduct impactful analyses and forecasting to support the commercial success of our cardiometabolic franchise. Reporting directly to the Director of Commercial Insights, Analytics & Operations, you will leverage market knowledge and your modeling expertise to generate in-depth, customer-focused analytical insights to ensure a successful product lifecycle.
This role is based in Pasadena, California, with an expectation to be in office 5 days a week.
Responsibilities
Data Analytics
- Conduct data analysis to support key commercial strategic imperatives and derive customer insights for the current indication and upcoming product launch.
- Present comprehensive insights and strategic recommendations to internal stakeholders including leadership, fostering informed decision-making at all levels.
- Challenge conventional norms with data-driven insights, fostering a culture of learning and advancement within Arrowhead.
Commercial Infrastructure and Data
- Refine and enhance business visualization dashboards based on evolving business needs to provide intuitive insights into key metrics and trends.
- Help establish processes for socializing insights to relevant stakeholders across the organization.
Forecasting
- With mentoring and guidance, update product forecasts based on new market data and internal insights (e.g., market research).
- Collaborate with finance in revenue planning processes.
Primary Market Research
- Work with business teams to understand key business questions and KPIs to be assessed, both through quantitative surveys trended over time and qualitative interviews.
Requirements
- Bachelor's degree in a business-related or life sciences field
- Strong understanding of the life sciences industry
- 5 years of progressive commercial experience in biotechnology or pharmaceuticals
- 3 years of experience in business analytics, forecasting, sales operations and/or market research
- Experience maintaining sophisticated market assessments and forecast models
- Strong analytical skills and attention to detail
- Proven communication and vendor management skills
- Ability to work collaboratively in a matrixed, team-based environment
- Strong organizational and time management capabilities
- Ability to travel up to 10% of time
- Current, valid authorization to work in the country where this role is located
Benefits
- Competitive Salaries
- Excellent Benefit Package
Company overview
Arrowhead Pharmaceuticals, Inc. is a publicly traded biotechnology company headquartered in Pasadena, California, specializing in the development of gene silencing therapeutics through RNA interference (RNAi) technology. Founded in 2004 and listed on Nasdaq under the ticker ARWR, the company focuses on treating intractable diseases by silencing disease-causing genes. Arrowhead's innovative TRiM (Targeted RNAi Molecule) platform enables precise targeting of specific messenger RNAs to reduce production of proteins associated with various conditions. The company's pipeline includes treatments for hepatitis B, liver diseases associated with alpha 1-antitrypsin deficiency, cardiovascular diseases, hypertriglyceridemia, and other metabolic disorders. With approximately 609 employees, Arrowhead has established significant partnerships with major pharmaceutical companies including Janssen, Amgen, and Takeda, demonstrating the commercial potential of its RNAi platform. The company recently achieved FDA approval for its therapy targeting Familial Chylomicronemia Syndrome (FCS), marking a significant milestone in its mission to revolutionize treatment approaches for challenging diseases.